SURAKSHA DIAGNOSTIC LTD (SURAKSHA) financials

SURAKSHA DIAGNOSTIC LTD (SURAKSHA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]

Market Cap: ₹1,552Cr.
Current Price: ₹298
Stock P/E: 42.2
ROE: 14.8%
ROCE: 17.8%
Book Value: ₹48.0
Dividend Yield: 0.17%
52W High / Low: ₹360/224

In Jun 2026, SURAKSHA DIAGNOSTIC LTD (SURAKSHA) reported sales ₹84 Cr and net profit ₹13 Cr.

Annual TTM: sales ₹314 Cr, net profit ₹37 Cr.

Shareholding: Promoters 49.10% (Sep 2026), FIIs 13.98% (Sep 2026), DIIs 21.56% (Sep 2026), Public 15.37% (Sep 2026), No. of Shareholders 60,792% (Sep 2026).

SURAKSHA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	66	59	64	70	76	76	79	84
Expenses	42	40	44	46	52	52	55	55
Operating Profit	24	18	20	24	24	23	24	29
OPM %	36%	31%	31%	34%	31%	31%	30%	34%
Other Income	1	1	1	1	1	1	1	2
Interest	2	2	2	3	3	3	4	4
Depreciation	9	9	9	9	10	10	11	11
Profit before tax	14	8	10	13	13	11	11	16
Tax %	24%	24%	20%	25%	25%	26%	36%	22%
Net Profit	11	6	8	10	9	8	7	13
EPS in Rs	2.49	1.22	1.54	1.89	1.80	1.56	1.29	2.42
Raw PDF	—	—	—	—	—	—	—	—

SURAKSHA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	158	140	223	190	219	249	301	314
Expenses	123	115	175	142	144	166	205	215
Operating Profit	34	25	48	48	74	84	96	100
OPM %	22%	18%	22%	25%	34%	34%	32%	32%
Other Income	2	-1	2	1	1	4	4	5
Interest	2	2	2	10	10	9	13	13
Depreciation	13	16	15	32	33	35	40	41
Profit before tax	21	6	33	8	33	44	47	50
Tax %	28%	-1%	28%	9%	25%	24%	28%	—
Net Profit	15	6	24	7	24	33	34	37
EPS in Rs	3.53	1.50	5.51	1.67	5.66	6.42	6.54	7.07
Dividend Payout %	0%	0%	0%	0%	0%	0%	1%	—

SURAKSHA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7	7	7	7	7	7	10	10
Reserves	96	111	118	141	148	172	204	239
Borrowings	22	13	18	21	99	92	89	128
Other Liabilities	43	42	28	32	29	30	30	72
Total Liabilities	168	173	171	201	282	302	333	450
Fixed Assets	127	128	119	119	195	211	215	284
CWIP	0	0	0	1	2	1	6	37
Investments	2	5	6	0	0	1	3	6
Other Assets	38	39	46	80	84	88	109	123
Total Assets	168	173	171	201	282	302	333	450

SURAKSHA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	—	31	24	42	45	61	63	80
Cash from Investing Activity	—	-20	-28	-44	-22	-35	-39	-51
Cash from Financing Activity	—	-10	3	1	-24	-26	-24	-28
Net Cash Flow	—	1	-1	-0	-1	0	-1	1
Free Cash Flow	—	15	5	24	32	22	28	30
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	—	111%	100%	97%	109%	94%	88%	97%

SURAKSHA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	48.78%	48.78%	48.89%	48.98%	49.00%	49.10%	49.10%	49.10%
FIIs	15.39%	14.46%	13.95%	13.73%	13.46%	13.46%	13.47%	13.98%
DIIs	20.43%	22.05%	22.37%	21.98%	22.57%	23.14%	23.22%	21.56%
Public	15.39%	14.71%	14.79%	15.30%	14.98%	14.31%	14.20%	15.37%
No. of Shareholders	98,662	87,275	79,670	75,304	70,963	67,107	64,866	60,792

SURAKSHA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	16	14	16	12	9	15	22	30
Inventory Days	107	93	62	38	81	89	101	82
Days Payable	176	227	177	84	184	192	176	196
Cash Conversion Cycle	-54	-120	-99	-34	-95	-88	-53	-84
Working Capital Days	6	-35	-19	-15	-48	-36	-14	-23
ROCE %	21%	18%	8%	23%	9%	17%	18%	18%

SURAKSHAUpdated 20 Oct 2026, 5:36

Suraksha Diagnostic Ltd

SURAKSHAUpdated 20 Oct 2026, 5:36

Market Cap

₹1,552Cr.

Current Price

₹298

High / Low

₹360/224

Stock P/E

42.2

ROE14.8%

ROCE17.8%

Book Value₹48.0

Face Value₹2.00

Dividend Yield0.17%

About

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Sep 2023	60	2	39	1	8	11	24	9	2.01
Dec 2023	51	2	36	1	8	7	24	5	1.14
Mar 2024	55	2	35	0	8	10	30	7	1.59
Jun 2024	60	2	39	1	9	11	26	8	1.93
Sep 2024	66	2	42	1	9	14	24	11	2.49
Dec 2024	59	2	40	1	9	8	24	6	1.22
Mar 2025	64	2	44	1	9	10	20	8	1.54
Jun 2025	70	3	46	1	9	13	25	10	1.89
Sep 2025	76	3	52	1	10	13	25	9	1.8
Dec 2025	76	3	52	1	10	11	26	8	1.56
Mar 2026	79	4	55	1	11	11	36	7	1.29
Jun 2026	84	4	55	2	11	16	22	13	2.42

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2018	132	4	105	1	12	12	28	9	2.08
Mar 2019	151	2	115	1	12	23	17	19	4.42
Mar 2020	158	2	123	2	13	21	28	15	3.53
Mar 2021	140	2	115	-1	16	6	-1	6	1.5
Mar 2022	223	2	175	2	15	33	28	24	5.51
Mar 2023	190	10	142	1	32	8	9	7	1.67
Mar 2024	219	10	144	1	33	33	25	24	5.66
Mar 2025	249	9	166	4	35	44	24	33	6.42
Mar 2026	301	13	205	4	40	47	28	34	6.54
TTM	314	13	215	5	41	50	—	37	7.07

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	49.1%
FIIs	13.98%
DIIs	21.56%
Public	15.37%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2024	48.78%	15.39%	20.43%	15.39%
Mar 2025	48.78%	14.46%	22.05%	14.71%
Jun 2025	48.89%	13.95%	22.37%	14.79%
Sep 2025	48.98%	13.73%	21.98%	15.3%
Dec 2025	49%	13.46%	22.57%	14.98%
Mar 2026	49.1%	13.46%	23.14%	14.31%
Jun 2026	49.1%	13.47%	23.22%	14.2%
Sep 2026	49.1%	13.98%	21.56%	15.37%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2018	7	79	27	33	145	96	6	10	33	145
Mar 2019	7	96	22	43	168	127	0	2	38	168
Mar 2020	7	111	13	42	173	128	0	5	39	173
Mar 2021	7	118	18	28	171	119	0	6	46	171
Mar 2022	7	141	21	32	201	119	1	0	80	201
Mar 2023	7	148	99	29	282	195	2	0	84	282
Mar 2024	7	172	92	30	302	211	1	1	88	302
Mar 2025	10	204	89	30	333	215	6	3	109	333
Mar 2026	10	239	128	72	450	284	37	6	123	450

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2018	—	—	—	—
Mar 2019	—	—	—	—
Mar 2020	31	-20	-10	1
Mar 2021	24	-28	3	-1
Mar 2022	42	-44	1	0
Mar 2023	45	-22	-24	-1
Mar 2024	61	-35	-26	0
Mar 2025	63	-39	-24	-1
Mar 2026	80	-51	-28	1

Key ratios

Historical financial ratios

Category	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	14	16	14	16	12	9	15	22	30
Inventory Days	90	107	93	62	38	81	89	101	82
Days Payable	256	176	227	177	84	184	192	176	196
Cash Conversion Cycle	-151	-54	-120	-99	-34	-95	-88	-53	-84
Working Capital Days	-9	6	-35	-19	-15	-48	-36	-14	-23
ROCE %	—	21%	18%	8%	23%	9%	17%	18%	18%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SURAKSHA DIAGNOSTIC LTD (SURAKSHA)?

The reported market capitalisation for SURAKSHA DIAGNOSTIC LTD (SURAKSHA) is ₹1,552Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SURAKSHA?

The current price shown for SURAKSHA DIAGNOSTIC LTD (SURAKSHA) on Fincrux is ₹298 with a 52-week high/low of ₹360/224.

What is the P/E ratio of SURAKSHA DIAGNOSTIC LTD (SURAKSHA)?

The stock P/E for SURAKSHA DIAGNOSTIC LTD (SURAKSHA) is 42.2 on Fincrux, with ROE at 14.8% and ROCE at 17.8%.

What were SURAKSHA latest quarterly results?

For Jun 2026, SURAKSHA DIAGNOSTIC LTD (SURAKSHA) reported sales ₹84 Cr and net profit ₹13 Cr (figures in ₹ crore unless noted).

What are SURAKSHA annual sales and net profit?

For TTM, SURAKSHA DIAGNOSTIC LTD (SURAKSHA) shows sales of ₹314 Cr and net profit of ₹37 Cr on the Fincrux profit & loss statement.

Who owns SURAKSHA DIAGNOSTIC LTD (SURAKSHA)?

Latest shareholding for SURAKSHA DIAGNOSTIC LTD (SURAKSHA) on Fincrux: Promoters 49.10% (Sep 2026), FIIs 13.98% (Sep 2026), DIIs 21.56% (Sep 2026), Public 15.37% (Sep 2026), No. of Shareholders 60,792% (Sep 2026).

Where can I find SURAKSHA DIAGNOSTIC LTD (SURAKSHA) financials?

SURAKSHA DIAGNOSTIC LTD (SURAKSHA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SURAKSHA balance sheet and cash flow?

Yes. The SURAKSHA DIAGNOSTIC LTD (SURAKSHA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 20 October 2026 at 5:36